Becton, Dickinson and Co (NYSE:BDXB.PFD)
$ 48.16 0.66 (1.39%) Market Cap: - Enterprise Value: - PE Ratio: 48.87 PB Ratio: 2.65 GF Score: 79/100

Becton Dickinson and Co at Wells Fargo Healthcare Conference Transcript

Sep 04, 2019 / 03:25PM GMT
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Analyst

All right. Good morning. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. It's my pleasure to host this fireside chat with the management team from Becton, Dickinson.

With us today, we have Tom Polen, who is the President; John Gallagher, Senior Vice President and the CFO of the Medical segment and the Treasurer. Also in the audience, we have Herman Cueto, I hope I pronounced your name correctly, Senior Vice President and CFO of the Interventional segment; and Tony DiMeo, Senior Director of Investor Relations. Gentlemen, thank you very much for being here today.

Thomas E. Polen
Becton, Dickinson and Company - President & COO

Yes. Thanks.

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Analyst

If anyone in the audience has a question, raise your hand and we'll call on you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot